Vascular change of hippocampal capillary is associated with vascular change of retinal capillary in aging

Brain Research Bulletin

Volumn 62, Issue 6, 2004, Pages 537-547

  Hagino, Nobuyoshi ^a,d   Kobayashi, Shinjiro ^a   Tsutsumi, Taiki ^a   Horiuchi, Seikoh ^b   Nagai, Ryoji ^b   Setalo, Gyury ^c   Dettrich, Erizabet ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b KUMAMOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF PÉCS   (Hungary)

^d HOKURIKU UNIVERSITY   (Japan)

Author keywords

Advanced Maillard reaction (glycation) end products; Aging; Culture; Hippocampus; Rat; Retina; Vascular deficiency

Indexed keywords

AGING; ANALYSIS OF VARIANCE; ANIMAL TISSUE; BRAIN CAPILLARY; BRAIN MICROCIRCULATION; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGRADATION; ENDOTHELIUM CELL; EXPERIMENTAL TEST; GLYCATION; HIPPOCAMPUS; MALE; MICROVASCULATURE; NONHUMAN; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; RAT; RETINA CAPILLARY; RETINA NEOVASCULARIZATION; SPROUTING; STATISTICAL ANALYSIS; VASCULAR DISEASE;

EID: 1342333856     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(03)00082-0     Document Type: Conference Paper

References (39)

1. Benson D.F., Kubl D.E., Hawkins R.A., Phelps M.E., Cumminge J.L., Tsai S.Y. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch. Neurol. 40:1983;711-714.
2. Benstein M.H., Hollenberg M.J. Fine structure of the choroidal capillaries and retinal capillaries. Invest. Ophthalmol. 4(1016):1965;1025.
3. Dickson D.W., Innisinicropi S., Yen S.H., Ko L.W., Matince L.A., Bucala R., Vlassara H. Glycation and microglia reaction in lesions of Alzheimer's disease. Neurobiol. Aging. 7:1996;733-743.
4. Fukushima T. Therapeutic efficacy of Toki-Shakuyaku-San for treatment for senile vascular dementia. Clin. Res. 710:1994;1065-1070.
5. Grubb R., Raichle M.E., Gado M.H., Eichling J.D., Huges C.P. Cerebral blood flow, oxygen utilization and blood volume in dementia. Neurology. 27:1977;905-910.
6. Hagino N. Kampo medicine is the potential therapeutics for treatment of dementia of Alzheimer type. Prog. Med. 16:1996;237-244.
7. Hagino N., Kobayashi S., Tsutsumi T., Horiuchi S., Nagai R. Changes of angiogenic potentials of choroidal capillary in young and old rats. FASEB J. 15:2001;A1079.
8. Harik S.I. Blood-brain barrier sodium/potassium pump: modulation by central noradrenergic innervation. Proc. Natl. Acad. Sci. U.S.A. 83:1986;4067-4070.
9. Hoyers S. Abnormalities of glucose metabolism in Alzheimer's disease. Ann. N.Y. Acad. Sci. 640:1991;53-58.
10. Inanaga K. Therapeutic efficacy of Tok-Shakuyaku-San for treatment for senile cognitive disorders. Prog. Med. 16:1996;293-300.
11. Iqbal K., Zaidi T., Thompson C.H., Merz P.A., Wisniewski H.M. Alzheimer paired helical filaments: bulk isolation solubility and protein composition. Acta Neuropathol. 62:1984;167-177.
12. Kimura K., Takamatsu J., Ikeda K., Kondo A., Miyakawa, Horiuchi S. Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons. Neurosci. Lett. 208:1996;53-56.
13. Kudo C., Sugiyama K. Therapeutic efficacy of Tok-Shakuyaku-San for treatment for senile dementia. Kampo Med. 16:1994;387-391.
14. Li J.L., Voisin D., Quiquerez A.L., Bouras C. Differential expression of advanced glycosylation end-products in neurons in different species. Brain Res. Bull. 641:1994;285-288.
15. Lindahl P., Johansson B.R., Leveen P., Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B deficient mice. Science. 277:1997;242-245.
16. Mazanet R., Franzini-Armstrong C. Scanning electron microscopy of pericytes in rat red muscle. Micovasc. Res. 23:1982;361-369.
17. Meier-Ruge W., Bertoni-Freddan C., Iwangnoff P. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease. Gerontology. 40:1994;246-252.
18. Meier-Ruge W., Hunziker O., Iwangoff P. Senile dementia: a threshold phenomenon of normal aging? A contribution to the functional reserve hypothesis of the brain. Ann. N.Y. Acad. Sci. 621:1991;104-118.
19. Meier-Ruge W., Iwangnoff P., Richlmeier K. Neurochemical enzyme changes in Alzheimer's and Pick's disease. Arch. Gerontol. Geriatr. 3:1984;161-165.
20. Mizushima N. Therapeutic efficacy of kampo medicine for senile dementia. Psychiatry Neurol. 5:1991;364-386.
21. Monnier V.M., Cerami A. Non-enzymatic browning in vivo: possible process for aging of long-lived proteins. Science. 211:1981;491-493.
22. Munch G., Cunningham M., Riederer P., Braak E. Advanced glycation end products are associated with Hirano bodies in Alzheimer's disease. Brain Res. Bull. 796:1998;307-310.
23. Perry G., Cras P., Kawai M., Mulvihill P., Tabaton M. Transformation of neurofibrillary tangles in the extra-cellular space. Bull. Clin. Neurosci. 56:1991;107-119.
24. Ruderman N.B., Ross P.S., Berger M., Goodman M.N. Regulation of glucose and keton-body metabolism in brain of anesthetized rats. Biochem. J. 138:1974;1-10.
25. Saito M. Therapeutic efficacy of Toki-Shakuyaku-San for treatment of senile dementia. Gendai Toyoigku. 14:1993;518-524.
26. Sakakura M. Therapeutic efficacy of Toki-Shakuyaku-San for treatment for senile dementia. Kampo Med. 16:1992;77-81.
27. Sasaki N., Fukatsu R., Tsuzuki K., Hayashi Y., Yoshida T., Fuji N., Koike T., Wakayama I., Yanagihara R., Garruto R., Amano N., Makita Z. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am. J. Pathol. 153:1998;1149-1155.
28. Sato Y., Kondo T., Oshima T. Estimation of age of human cadaverous by immunohistochemical assessment of advance glycation end products in the hippocampus. Histopathology. 38:2001;217-220.
29. Schnider S.L., Kohnn R.R. Effect of age and diabetes mellitus on the solubility of collagen from human skin, trachea cartilage and dura matter. Exp. Genetol. 17:1982;187-194.
30. Selkoe D.J. Normal and abnormal biology of the beta-amyloid precursor protein. Ann. Rev. Neurosci. 17:1994;489-517.
31. Simpson I.A., Koteswara R., Chudu I., Davis-Hill T., Honer W.G., Davies P. Decrease concentration of Glut-1 and Glut-3 glucose transportation in brain of patients with Alzheimer's disease. Ann. Neurol. 35:1994;546-551.
32. Smith M.A., Tenda S., Richey P.L., Miyata S., Yans D., Stern D., Sayne L.M., Monnier V.M., Perry G. Advanced Maillard reaction products are associated with Alzheimer's disease pathology. Proc. Natl. Acad. Sci. U.S.A. 91:1994;5710-5714.
33. Snowden J.M. The effect of polymers on the shrinkage temperature of tendon. Biochim. Biophys. Acta. 707:1982;142-146.
34. Stewart P.A., Hayakawa K., Akers M.A., Vinter H.V. A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab. Invest. 67:1992;734-742.
35. Takeda A., Yasuda T., Miyata T., Mizuno K., Li M., Yoneyama S., Horie K., Maeda K., Sobue G. Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain. Neurosci. Lett. 221:1996;17-20.
36. Tilton R.G., Kilo C., Williamson J.R., Murch W. Differences in pericyte contractile function in rat cardiac and skeletal muscle microvasculatures. Microvasc. Res. 18:1979;336-352.
37. Tucek S., Rincy J., Dolazal V. Advance in the biology of cholinergic neurons. Adv. Neurol. 51:1990;109-115.
38. Vitek M.P., Bhattacharya K., Glendening J.M., Stopa E., Vlassara H., Bucala R., Mangue K., Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 91:1994;4766-4770.
39. Yamagishi S., Kobayashi K., Yamamoto H. Vascular pericytes not only regulate growth, but also preserve postcyclin-producing ability and protect against lipid peroxide-induced injury of co-culture endothelial cells. Biochem. Biophys. Res. Commun. 190:1993;418-425.